Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer

Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2005-03, Vol.113 (6), p.1022-1025
Hauptverfasser: Masasyesva, Brett G., Tong, Betty C., Brock, Malcolm V., Pilkington, Thomas, Goldenberg, David, Sidransky, David, Harden, Susan, Westra, William H., Califano, Joseph
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1025
container_issue 6
container_start_page 1022
container_title International journal of cancer
container_volume 113
creator Masasyesva, Brett G.
Tong, Betty C.
Brock, Malcolm V.
Pilkington, Thomas
Goldenberg, David
Sidransky, David
Harden, Susan
Westra, William H.
Califano, Joseph
description Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ijc.20683
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67350065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67350065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</originalsourceid><addsrcrecordid>eNp10E1LwzAYB_AgipvTg19AclHw0O1J0rT1KMOXycSLnjyUNH0yMrJ2Ji2yb2-0g508JZBfnpc_IZcMpgyAz-xaTzlkhTgiYwZ3eQKcyWMyjm-Q5ExkI3IWwhqAMQnpKRkxKeON8TH5fG0d6t4pTzfKr2xDVaPcLthAtx5rq7tAXauVoz4y77HRSJXp0NPQV66t4kePAXVn24a2hrq-WVGtIvPn5MQoF_Bif07Ix-PD-_w5Wb49Leb3y0SnMhUJy3NMgcuMMVAFrxmXYKS5M0xjnWaFVNKIXGGcXgleaISUF4VkKtUoqiITE3Iz1N369qvH0JUbGzQ6pxps-1BmuZAAmYzwdoDatyF4NOXW27j2rmRQ_iZZxiTLvySjvdoX7asN1ge5jy6C6z1QIeZjfNzZhoPLUsk5z6ObDe7bOtz937FcvMyH1j9RXImx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67350065</pqid></control><display><type>article</type><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</creator><creatorcontrib>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</creatorcontrib><description>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.20683</identifier><identifier>PMID: 15515012</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - surgery ; DNA Primers ; gap ligase ; Humans ; k‐ras ; lung cancer ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Medical sciences ; mutation detection ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Pneumology ; Polymerase Chain Reaction ; Retrospective Studies ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>International journal of cancer, 2005-03, Vol.113 (6), p.1022-1025</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>2005 INIST-CNRS</rights><rights>(c) 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</citedby><cites>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.20683$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.20683$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16452227$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15515012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masasyesva, Brett G.</creatorcontrib><creatorcontrib>Tong, Betty C.</creatorcontrib><creatorcontrib>Brock, Malcolm V.</creatorcontrib><creatorcontrib>Pilkington, Thomas</creatorcontrib><creatorcontrib>Goldenberg, David</creatorcontrib><creatorcontrib>Sidransky, David</creatorcontrib><creatorcontrib>Harden, Susan</creatorcontrib><creatorcontrib>Westra, William H.</creatorcontrib><creatorcontrib>Califano, Joseph</creatorcontrib><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>DNA Primers</subject><subject>gap ligase</subject><subject>Humans</subject><subject>k‐ras</subject><subject>lung cancer</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Medical sciences</subject><subject>mutation detection</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Polymerase Chain Reaction</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1LwzAYB_AgipvTg19AclHw0O1J0rT1KMOXycSLnjyUNH0yMrJ2Ji2yb2-0g508JZBfnpc_IZcMpgyAz-xaTzlkhTgiYwZ3eQKcyWMyjm-Q5ExkI3IWwhqAMQnpKRkxKeON8TH5fG0d6t4pTzfKr2xDVaPcLthAtx5rq7tAXauVoz4y77HRSJXp0NPQV66t4kePAXVn24a2hrq-WVGtIvPn5MQoF_Bif07Ix-PD-_w5Wb49Leb3y0SnMhUJy3NMgcuMMVAFrxmXYKS5M0xjnWaFVNKIXGGcXgleaISUF4VkKtUoqiITE3Iz1N369qvH0JUbGzQ6pxps-1BmuZAAmYzwdoDatyF4NOXW27j2rmRQ_iZZxiTLvySjvdoX7asN1ge5jy6C6z1QIeZjfNzZhoPLUsk5z6ObDe7bOtz937FcvMyH1j9RXImx</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Masasyesva, Brett G.</creator><creator>Tong, Betty C.</creator><creator>Brock, Malcolm V.</creator><creator>Pilkington, Thomas</creator><creator>Goldenberg, David</creator><creator>Sidransky, David</creator><creator>Harden, Susan</creator><creator>Westra, William H.</creator><creator>Califano, Joseph</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><author>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>DNA Primers</topic><topic>gap ligase</topic><topic>Humans</topic><topic>k‐ras</topic><topic>lung cancer</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Medical sciences</topic><topic>mutation detection</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Polymerase Chain Reaction</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masasyesva, Brett G.</creatorcontrib><creatorcontrib>Tong, Betty C.</creatorcontrib><creatorcontrib>Brock, Malcolm V.</creatorcontrib><creatorcontrib>Pilkington, Thomas</creatorcontrib><creatorcontrib>Goldenberg, David</creatorcontrib><creatorcontrib>Sidransky, David</creatorcontrib><creatorcontrib>Harden, Susan</creatorcontrib><creatorcontrib>Westra, William H.</creatorcontrib><creatorcontrib>Califano, Joseph</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masasyesva, Brett G.</au><au>Tong, Betty C.</au><au>Brock, Malcolm V.</au><au>Pilkington, Thomas</au><au>Goldenberg, David</au><au>Sidransky, David</au><au>Harden, Susan</au><au>Westra, William H.</au><au>Califano, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>113</volume><issue>6</issue><spage>1022</spage><epage>1025</epage><pages>1022-1025</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15515012</pmid><doi>10.1002/ijc.20683</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2005-03, Vol.113 (6), p.1022-1025
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_67350065
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - surgery
DNA Primers
gap ligase
Humans
k‐ras
lung cancer
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Medical sciences
mutation detection
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Pneumology
Polymerase Chain Reaction
Retrospective Studies
Tumors
Tumors of the respiratory system and mediastinum
title Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T22%3A42%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20margin%20analysis%20predicts%20local%20recurrence%20after%20sublobar%20resection%20of%20lung%20cancer&rft.jtitle=International%20journal%20of%20cancer&rft.au=Masasyesva,%20Brett%20G.&rft.date=2005-03-01&rft.volume=113&rft.issue=6&rft.spage=1022&rft.epage=1025&rft.pages=1022-1025&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.20683&rft_dat=%3Cproquest_cross%3E67350065%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67350065&rft_id=info:pmid/15515012&rfr_iscdi=true